Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Luye Pharma Group Ltd.
* To assess the relative bioavailability of LY03004 compared to Risperdal® Consta® at 25 mg following multiple intramuscular injections at steady-state; * To evaluate the safety and tolerability of LY03004 following repeated intramuscular injections * To evaluate the preliminary efficacy of LY03004 following repeated intramuscular injections
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted